ArticleStructural heart : the journal of the Heart Team2025
Acute Frame Recoil Following Transcatheter Mitral Valve-in-Valve Replacement: Incidence and Impact on Hemodynamics.
Article in Structural heart : the journal of the Heart Team, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transcatheter mitral valve-in-valve replacement (ViV-TMVR) using balloon-expandable transcatheter heart valves (THVs) has emerged as a promising treatment for patients with degenerative bioprosthetic mitral valves. While the phenomenon of acute elastic recoil of the valve frame is well-recognized in transcatheter aortic valve implantation, its impact in the context of ViV-TMVR remains unexplored. Our study objective was to evaluate the incidence, magnitude, and hemodynamic impact of acute frame recoil. Methods: This retrospective study analyzed 70 patients (61% female, median age 76) who underwent ViV-TMVR (July 2016-July 2022). Recoil was measured using angiographic images at full balloon expansion and immediately after deflation. Measurements were taken at 3 THV levels (left atrium, mid-level, and ventricular). Recoil was calculated as the absolute and relative difference in frame diameter before and after balloon deflation. Results: Mean frame diameter decreased after balloon deflation. Mean absolute and relative recoil were 0.68 ± 0.33 mm and 2.62% ± 1.37%, respectively, peaking at the THV waist (3.46% ± 2.34%). Recoil increased with balloon-sizing ratio and decreased after postdilation. Recoil at prosthesis waist is positively associated with 30-day and 1-year TMMG, even after adjusting for the true internal diameter of the surgical heart valve, THV size, anticoagulant prescription at discharge, predischarge TMMG, and heart rate. Conclusions: Higher frame recoil following ViV-TMVR is associated with higher TMMG at 30-day and 1-year follow-ups. Optimizing balloon sizing may reduce recoil, improve valve performance, and enhance long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.